Company: PIII
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001628280-25-015305
Chunk: 301

Company: P3 Health Partners Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 8
Chunk 301
---
 stock units, net of shares withheld for tax—204———(16)—(16)Issuance of restricted stock awards —250—————— At-the-market sales, net of offering costs—27———33—33 Equity-based compensation785————5,194—5,194 Restricted stock unit awards issued in satisfaction of executive transaction bonuses—————5,000—5,000 Fair value adjustment to redeemable non-controlling interest20,579 ————(20,579)—(20,579)Remeasurement adjustment to redeemable non-controlling interest resulting from ownership changes(117,860)— — — — 117,860 — 117,860 Private placement, net of offering costs—69,1577——86,576—86,583 Net loss(128,653)— — — — — (57,773)(57,773)STOCKHOLDERS’ EQUITY, December 31, 2023291,532 116,588 12 196,569 20 509,442 (367,344)142,130 Exchanges of redeemable non-controlling interest for Class A common stock—612— (612)— — —— Issuance of Class A common stock upon settlement of restricted stock units, net of shares withheld for tax—4,066———(103)—(103)Equity-based compensation—————5,752 —5,752 Fair value adjustment to redeemable non-controlling interest(20,579)————20,579 —20,579 Remeasurement adjustment to redeemable non-controlling interest resulting from ownership changes(22,831)— — — — 22,831 — 22,831 Private placement, net of offering costs—41,6044——8,465 —8,469 Class A common stock warrants issued—————12,127 —12,127 Net loss(174,529)— — — — — (135,849)(135,849)STOCKHOLDERS’ EQUITY, December 31, 2024$73,593 162,870 $16 195,957 $20 $579,093 $(503,193)$75,936 

See accompanying notes to consolidated financial statements.

P3 Health Partners Inc. | 2024 Form 10-K |